Laura Bower

CSC Corporate Domains Rackspace MailGun Mimecast ServiceNow MailChimp SPF Google Cloud Hosting Drupal Taleo Oracle Cloud VueJS WP Engine OneTrust Salesforce Nginx Vimeo MouseFlow WordPress.org Google Tag Manager Mobile Friendly Hotjar Google Analytics New Relic Remote AI

biopharmaceuticals rare genetic diseases cellular metabolism hemolytic anemias healthcare biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing rare diseases hemolytic anemia pyruvate kinase deficiency thalassemia sickle cell disease clinical trials patient support fda approval therapeutic development disease-modifying therapies investigational drugs genetic disorders orphan drugs patient engagement healthcare providers clinical data research pipeline drug discovery metabolic disease patient resources collaboration health outcomes investor relations corporate governance social responsibility diversity & inclusion hematology treatment access patient advocacy scientific research clinical studies drug activation immunology genetic mutations commercialization healthcare strategy therapeutic areas community engagement ethics in healthcare healthcare innovation bioethics medical research sustainable practices employee engagement career opportunities patient care access to medicines oncology precision medicine pyruvate kinase activators acquired anemia mitapivat tebapivat patient-centric approach innovative therapies inborn errors of metabolism patient support services cancer metabolism therapeutic pipeline healthcare professionals regulatory approval clinical development unmet medical needs scientific excellence transformative therapies specialized market genetic basis patient communities healthcare partnerships competitive landscape health wellness & fitness hospital & health care pharmaceuticals medical